Final ID: Mo2052
Dubrock Hilary, Wieczorek Mikolaj, Hackett Sarah, Alger Heather, Carlson Katherine, Klugherz Paul, Carter Rickey, Wagner Tyler, Johnson Patrick, Frantz Robert, Strom Jordan, Waks Jonathan, Agarwal Richa, Hemnes Anna, Steinberg Benjamin, Pandey Ambarish
Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Cardiac Adverse Events in Patients with Non-small Cell Lung Cancer Treated with Osimertinib Compared to ControlWin Zin, Aboaid Hazem, Nguyen Kevin, Myat Yin, Chu Matthew, Mohib Khadija, Macias Aziel, Htwe Khaing Khaing, Thein Kyaw, Hussain Abbas, Srinivasmurthy Ramaditya, Hattin Riccesha, Jones Daniel, Nanda Rishi, Ta Jason, Chu Timothy, Tun Tin